| 11/20/2026 3:10 PM | Legend Biotech (1801198) Issuer Zhang Ingrid (1964342) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/10/2026 6:11 AM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 11/05/2026 12:19 PM | FMR LLC (315066) Filed by Legend Biotech (1801198) Subject | Form SCHEDULE 13G/A | |
| 11/04/2026 8:00 AM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/15/2026 7:00 AM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/13/2026 6:30 AM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 10/07/2026 3:15 PM | Legend Biotech (1801198) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 10/01/2026 3:04 PM | Legend Biotech (1801198) Issuer Sanders Corazon (0) Corsee | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/29/2026 1:31 PM | Legend Biotech (1801198) Subject Sanders Corazon (0) Corsee | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/25/2026 6:00 AM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/24/2026 3:00 PM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for LEGN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Legend Biotech and its competitors with MarketBeat's FREE daily newsletter.
|
| 09/23/2026 3:15 PM | Legend Biotech (1801198) Issuer Santos Carlos E (2097065) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/22/2026 2:30 PM | Legend Biotech (1801198) Subject Santos Carlos E (2097065) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/22/2026 1:33 PM | Huang Ying (1967360) Reporting Legend Biotech (1801198) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/16/2026 3:16 PM | Legend Biotech (1801198) Issuer Zhang Ingrid (1964342) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 09/16/2026 3:18 PM | Legend Biotech (1801198) Issuer Zhang Ingrid (1964342) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/15/2026 7:00 AM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 09/14/2026 7:00 AM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/18/2026 3:01 PM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/11/2026 6:53 AM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 08/06/2026 9:31 AM | FMR LLC (315066) Filed by Legend Biotech (1801198) Subject | Form SCHEDULE 13G/A | |
| 08/03/2026 4:02 PM | BASH ALAN (1908421) Reporting Legend Biotech (1801198) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 07/15/2026 6:30 AM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 07/02/2026 3:05 PM | Huang Ying (1967360) Reporting Legend Biotech (1801198) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/02/2026 3:05 PM | Casey Patrick John (2068365) Reporting Legend Biotech (1801198) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/30/2026 9:46 AM | Casey Patrick John (2068365) Reporting Legend Biotech (1801198) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/29/2026 8:53 PM | Huang Ying (1967360) Reporting Legend Biotech (1801198) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/26/2026 2:23 PM | Huang Ying (1967360) Reporting Legend Biotech (1801198) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/22/2026 3:19 PM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/18/2026 3:36 PM | Legend Biotech (1801198) Filer | Form 424B5 | |
| 06/17/2026 3:42 PM | JPMorgan Chase Bank, N.A. - ADR Depositary (1474274) Filed by Legend Biotech (1801198) Subject | Form F-6EF | |
| 06/17/2026 3:50 PM | Legend Biotech (1801198) Filer | Form 424B5 | |
| 06/15/2026 7:00 AM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/02/2026 8:30 AM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 06/01/2026 9:00 AM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 05/12/2026 6:06 AM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 04/14/2026 6:30 AM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 03/27/2026 3:25 PM | Huang Ying (1967360) Reporting Legend Biotech (1801198) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/26/2026 3:27 PM | Huang Ying (1967360) Reporting Legend Biotech (1801198) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/26/2026 3:20 PM | Legend Biotech (1801198) Subject Yeung Jessie (2052734) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/18/2026 5:59 PM | Casey Patrick John (2068365) Reporting Legend Biotech (1801198) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
Whoops! I wasn’t supposed to share this with you yet (Ad) Traders have paid as much as $500 for technology like this. Thomas Wood of Base Camp Trading is offering his proprietary Snapback Indicator for just $7.
There is no subscription and no recurring charge, and it's yours for life. The indicator is designed to help identify potential market turning points, showing when it may be time to buy, sell, or go short. Get the Snapback Indicator for just $7 and see why Thomas Wood is offering it. |
| 03/18/2026 6:01 PM | Legend Biotech (1801198) Issuer Salovey Peter (2088468) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:02 PM | Legend Biotech (1801198) Issuer Meng Robin (2114170) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 6:04 PM | Heyman Tomas J. (1814673) Reporting Legend Biotech (1801198) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 5:48 PM | Legend Biotech (1801198) Issuer Wang Ye (2114160) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 5:50 PM | Huang Ying (1967360) Reporting Legend Biotech (1801198) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 5:51 PM | Legend Biotech (1801198) Issuer Sanders Corazon (0) Corsee | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 5:52 PM | Legend Biotech (1801198) Issuer Santos Carlos E (2097065) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 5:54 PM | Legend Biotech (1801198) Issuer Zhang Fangliang (1845292) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 5:55 PM | Ji Darren Xiaohui (1974687) Reporting Legend Biotech (1801198) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 5:57 PM | Legend Biotech (1801198) Issuer Mao Li (2106809) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 03/18/2026 5:58 PM | Kung Gareth (2121501) Reporting Legend Biotech (1801198) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 03/10/2026 10:45 AM | Legend Biotech (1801198) Filer | Form 20-F Registration statement / Annual report / Transition report | |
| 03/10/2026 6:00 AM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/23/2026 7:00 AM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/21/2026 6:30 AM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 01/12/2026 7:00 AM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
| 12/29/2025 6:28 AM | Huang Ying (1967360) Reporting Legend Biotech (1801198) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/29/2025 5:40 AM | Huang Ying (1967360) Reporting Legend Biotech (1801198) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/29/2025 5:45 AM | Legend Biotech (1801198) Subject Sanders Corazon (0) Corsee | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/08/2025 6:30 AM | Legend Biotech (1801198) Filer | Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |